The conditions we treat most frequently with BPC-157 in this category include Achilles tendinopathy, patellar tendinitis, lateral epicondylitis (tennis elbow), rotator cuff partial tears, partial ACL and MCL tears, and chronic ankle instability
Based on current pharmacovigilance and cohort data, several factors appear to increase risk: 1 1 Pre-existing androgenetic alopecia , patients with a genetic predisposition to male or female pattern hair loss, may see it accelerate or become newly noticeable during rapid weight loss
Research shows that GLP-1 agonists can decrease A1C by as much as 1.5% to 2%, whereas SGLT2 inhibitors typically provide a reduction of about 1%
Petrie MC, Verma S, Docherty KF, Inzucchi SE, Anand I, Blohlvek J, et al